Desmethyl erlotinib carboxylate acid
CAS: 882172-60-3
Rif. 3D-FD21266
| 1mg | Fuori produzione | ||
| 2mg | Fuori produzione | ||
| 5mg | Fuori produzione |
Informazioni sul prodotto
Nome:
Desmethyl erlotinib carboxylate acid
Sinonimi:
- 2-[[4-[(3-Ethynylphenyl)amino]-6-(2-methoxyethoxy)-7-quinazolinyl]oxy]
Descrizione:
Erlotinib is a drug that inhibits the enzyme tyrosine kinase, which is required for the growth and spread of cancer cells. It is used to treat patients with advanced non-small cell lung cancer and has been shown to have activity against other types of cancer. Erlotinib targets the epidermal growth factor receptor (EGFR), a protein that plays an important role in many cancers. Erlotinib binds to EGFR and prevents it from binding with its ligands, preventing signalling. Erlotinib also interacts with other proteins such as HER2/neu, c-kit, c-met, and PDGFRA/CD140B, which are involved in various cellular processes including proliferation, differentiation, apoptosis, and adhesion.
Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:
Proprietà chimiche
Peso molecolare:
393.39 g/mol
Formula:
C21H19N3O5
Purezza:
Min. 95%
InChI:
InChI=1S/CH4/h1H4
InChI key:
InChIKey=VNWKTOKETHGBQD-UHFFFAOYSA-N
SMILES:
C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCC(=O)O)cc23)c1
MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:
